Cite
HARVARD Citation
Helliwell, P. et al. (2014). SAT0403 Further Analysis of Psoriatic Arthritis Disease Activity Score (PASDAS) and Composite Psoriatic Disease Activity Index (CPDAI) Using Data from A Placebo-Controlled TRIAL of Certolizumab Pegol in Psoriatic Arthritis. Annals of the rheumatic diseases. p. 740. [Online].